Australian pharma takes credit for helping return budget to surplus

30 January 2012

The Australian pharmaceutical industry is making a major contribution to returning the Federal Budget to surplus, trade group Medicines Australia chief executive Brendan Shaw reminded Treasurer and Deputy Prime Minister Wayne Swan yesterday.

In Medicines Australia's pre-Budget submission to the Treasurer, Dr Shaw underscored the importance of Medicines Australia's Memorandum of Understanding with the Commonwealth which was delivering A$1.9 billion ($2.02 billion) in savings to the Pharmaceutical Benefits Scheme.

Estimates commissioned by the government show that the original 2007 reforms to the PBS will generate up to A$5.8 billion in savings by 2018, Dr Shaw told the Treasurer in a letter. The PBS grew by just 2.4% in nominal terms in 2011, less than the inflation rate of 3.1%, suggesting that government spending on the PBS fell in real terms in 2011.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical